MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C von Zhu, Nan, Chen, Mo, Eng, Rowena, DeJong, Joshua, Sinha, Amit U, Rahnamay, Noushin F, Koche, Richard, Al-Shahrour, Fatima, Minehart, Janna C, Chen, Chun-Wei, Deshpande, Aniruddha J, Xu, Haiming, Chu, S Haihua, Ebert, Benjamin L, Roeder, Robert G, Armstrong, Scott A

Volltext

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response von Amatangelo, Michael D., Quek, Lynn, Shih, Alan, Stein, Eytan M., Roshal, Mikhail, David, Muriel D., Marteyn, Benoit, Farnoud, Noushin Rahnamay, de Botton, Stephane, Bernard, Olivier A., Wu, Bin, Yen, Katharine E., Tallman, Martin S., Papaemmanuil, Elli, Penard-Lacronique, Virginie, Thakurta, Anjan, Vyas, Paresh, Levine, Ross L.

Volltext

De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features von Epstein-Peterson, Zachary D., Spitzer, Barbara, Derkach, Andriy, Arango, Juan E., McCarter, Joseph G.W., Medina-Martínez, Juan S., McGovern, Erin, Farnoud, Noushin Rahnamay, Levine, Ross L., Tallman, Martin S.

Volltext

Patient Derived Xenograft (PDX) Models Recapitulate the Genomic-Driver Composition of Acute Leukemia Samples von Krivtsov, Andrei V., Wang, Xujun, Farnoud, Noushin Rahnamay, Hadler, Michael, Martin, Marta Sanchez, Knapp, Kristina M., Stein, Eytan M., Lipson, Doron, Nahas, Michelle K., Stephens, Philip J., Sanford, Eric M, Wang, Kai, Frampton, Garrett M, Brennan, Tim, Otto, Geoff A., Yelensky, Roman, Miller, Vincent, Levine, Ross L., Ferrando, Adolfo A., Armstrong, Scott A.

Volltext